Givaudan (OTCMKTS:GVDNY) Sets New 12-Month Low – Here’s Why

Givaudan SA (OTCMKTS:GVDNY)’s stock price reached a new 52-week low on Tuesday . The stock traded as low as $66.54 and last traded at $66.82, with a volume of 10407 shares trading hands. The stock had previously closed at $68.8150.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Givaudan in a research note on Friday, January 30th. The Goldman Sachs Group cut shares of Givaudan from a “strong-buy” rating to a “sell” rating in a report on Tuesday, February 10th. Finally, Citigroup restated a “neutral” rating on shares of Givaudan in a report on Tuesday, February 3rd. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Givaudan currently has a consensus rating of “Moderate Buy”.

Givaudan Price Performance

The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.13 and a current ratio of 1.74. The firm’s fifty day moving average price is $77.08 and its 200-day moving average price is $80.74.

Givaudan Company Profile

Givaudan is a Swiss-based global company that develops, manufactures and supplies flavors, fragrances and active cosmetic ingredients for a broad range of consumer products. The company’s core activities are organized around creating taste and scent solutions—ranging from fine fragrances and consumer-packaged goods scents to flavor systems for food and beverages and functional ingredients for personal care. Givaudan works with brand owners and manufacturers to design sensory experiences, improve product performance and meet formulation or regulatory requirements.

Its product and service offerings include bespoke fragrance creation, flavor formulation, natural ingredient sourcing, aroma chemicals, taste modulators and application support such as prototyping and sensory testing.